Concepedia

Publication | Open Access

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

DOIFull Paper Access

376

Citations

36

References

2020

Year

Dorottya Laczkó, Michael J. Hogan, Sushila A. Toulmin, Philip Hicks, Katlyn Lederer, Brian T. Gaudette, Diana Castaño, Fatima Amanat, Hiromi Muramatsu, Thomas H. Oguin,
Immunity

References

YearCitations

WHO Declares COVID-19 a Pandemic.

Domenico Cucinotta, Maurizio Vanelli

PubMed

2020

7.7K

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael,

New England Journal of Medicine

2020

3.4K

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Katalin Karikó, Michael Buckstein, Houping Ni,

Immunity

2005

2.5K

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier,

Nature Medicine

2020

1.9K

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Katalin Karikó, Hiromi Muramatsu, Frank A. Welsh,

Molecular Therapy

2008

1.8K

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao, Linlin Bao, Haiyan Mao,

Science

2020

1.5K

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Linlin Bao, Wei Deng, Baoying Huang,

Nature

2020

1.2K

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

Jingyou Yu, Lisa H. Tostanoski, Lauren Peter,

Science

2020

1.1K

Lethal Infection of K18- <i>hACE2</i> Mice Infected with Severe Acute Respiratory Syndrome Coronavirus

Paul B. McCray, Lecia L. Pewe, Christine Wohlford-Lenane,

Journal of Virology

2006

1.1K

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu,

Journal of Controlled Release

2015

980

Page 1